Dupilumab for chronic actinic dermatitis: A case series and review of the literature.

This article discusses the use of dupilumab, a medication, for the treatment of chronic actinic dermatitis (CAD), a rare photosensitive disorder that primarily affects older men. The article presents two case studies of patients with CAD who were successfully treated with dupilumab, showing significant improvement in their symptoms. The article also reviews existing literature on the use of dupilumab for CAD and suggests the need for further studies to confirm its effectiveness. The document is a case series that includes information on patients with various medical conditions and the treatments they received, predominantly male patients treated with medications like hydroxychloroquine, methotrexate, and mycophenolate mofetil. The document also provides information on abbreviations used and conflicts of interest of the authors. Ethical approval was not required for this case series, and patient consent was obtained for the use of their information and images. [Extracted from the article]